http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#Head http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#assertion http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#provenance http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#pubinfo http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#assertion http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object https://identifiers.org/MONDO:0005384 http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/CHEBI:42797 http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#association http://www.w3.org/2000/01/rdf-schema#label Gabapentin capsules, USP are indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in patients over 12 years of age with epilepsy. Gabapentin capsules, USP are also indicated as adjunctive therapy in the treatment of partial seizures in pediatric patients age 3 to 12 years. http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#association https://w3id.org/biolink/vocab/has_population_context http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#cohort http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#association https://w3id.org/biolink/vocab/provided_by NeuroDKG http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#association https://w3id.org/biolink/vocab/publications https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0936a88f-b569-49c4-951b-14e8f6273b53 http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#cohort http://www.w3.org/2000/01/rdf-schema#label patients over 12 years of age with epilepsy; pediatric patients age 3 to 12 years http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#cohort https://schema.org/requiredMinAge 3 http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#cohort https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Cohort http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#cohort https://w3id.org/biolink/vocab/has_phenotype https://identifiers.org/MONDO:0005027 https://identifiers.org/CHEBI:42797 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug https://identifiers.org/MONDO:0005384 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#provenance http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#pubinfo http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#sig http://purl.org/nanopub/x/hasSignature GVpwbVsPxdD1f0XxN6kIIbt3FXkUD3+ag41SVjR6oHAYRWweMYyWsf8tqTaWLj6rJAonzXr0SSgy7RU5lT7angfwR07qLMOmCz/2biSDvAMoyaW8xaiEHw1OpUNzZkphxiRZbE/tM2Y0YpJWkjtxJcWASd8NS2QbXRFHdCIagbA= http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk http://purl.org/dc/terms/created 2021-03-28T18:53:09.384+02:00 http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RA_MJldfjvpLFE5RF0tMG5eHg4tYnbjd3JOCMsQxqTNzk https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RA59AEpaWRaR9sjdA0-n4zaQWdiZ6--iGafMrjrDAOheI